Literature DB >> 12750959

Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases.

J Gómez-Cerezo1, I Suárez, J J Ríos, P Peña, M J García de Miguel, M de José, O Monteagudo, P Linares, A Barbado-Cano, J J Vázquez.   

Abstract

Fifty-four cases of Achromobacter xylosoxidans bacteremia diagnosed over a 10-year period in patients from 2 months to 87 years of age were reviewed. Fifty-two episodes were nosocomial. The most frequent underlying condition was neoplasm (solid or hematological). The source of infection was a contaminated intravenous catheter in 35 patients (60%) and pneumonia in 6 patients. Eight (15%) patients died. The only risk factors significantly associated with mortality were age over 65 years and neutropenia. The results of in vitro susceptibility studies of the isolates showed that antibiotic therapy with antipseudomonal penicillins or carbapenems would be a reasonable choice. An epidemiological study conducted in the hemodialysis unit showed Achromobacter xylosoxidans in tap water and on the hands of two healthcare workers but not in the hemodialysis systems. Patients were probably contaminated when healthcare workers manipulated the intravenous catheters without wearing gloves.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750959     DOI: 10.1007/s10096-003-0925-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

Review 1.  Infectious complications of indwelling vascular catheters.

Authors:  I I Raad; G P Bodey
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079

Review 2.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

Review 3.  Water as a reservoir of nosocomial pathogens.

Authors:  W A Rutala; D J Weber
Journal:  Infect Control Hosp Epidemiol       Date:  1997-09       Impact factor: 3.254

Review 4.  Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature.

Authors:  J M Duggan; S J Goldstein; C E Chenoweth; C A Kauffman; S F Bradley
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

5.  Achromobacter xylosoxidans bacteremia in patients with hematologic malignancies.

Authors:  J A Hernández; R Martino; R Pericas; A Sureda; S Brunet; A Domingo-Albós
Journal:  Haematologica       Date:  1998-03       Impact factor: 9.941

6.  Nosocomial outbreak of Achromobacter xylosoxidans associated with a diagnostic contrast solution.

Authors:  J Reina; M Antich; B Siquier; P Alomar
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

Review 7.  Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus.

Authors:  R Manfredi; A Nanetti; M Ferri; F Chiodo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

8.  A semiquantitative culture method for identifying intravenous-catheter-related infection.

Authors:  D G Maki; C E Weise; H W Sarafin
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

9.  Infection by Alcaligenes xylosoxidans subsp. xylosoxidans in neutropenic patients.

Authors:  M Knippschild; E N Schmid; M Uppenkamp; E König; P Meusers; G Brittinger; H G Höffkes
Journal:  Oncology       Date:  1996 May-Jun       Impact factor: 2.935

10.  Nosocomial colonization and infection by Achromobacter xylosoxidans.

Authors:  M E Reverdy; J Freney; J Fleurette; M Coulet; M Surgot; D Marmet; C Ploton
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

View more
  55 in total

1.  Genome sequence of the highly efficient arsenite-oxidizing bacterium Achromobacter arsenitoxydans SY8.

Authors:  Xiangyang Li; Yao Hu; Jing Gong; Yanbing Lin; Laurel Johnstone; Christopher Rensing; Gejiao Wang
Journal:  J Bacteriol       Date:  2012-03       Impact factor: 3.490

2.  VIM-2 metallo-beta-lactamase in Achromobacter xylosoxidans in Europe.

Authors:  D Sofianou; A Markogiannakis; E Metzidie; S Pournaras; A Tsakris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

3.  Outbreak of Achromobacter xylosoxidans pseudobacteremia in a neonatal care unit related to contaminated chlorhexidine solution.

Authors:  J Molina-Cabrillana; C Santana-Reyes; A González-García; A Bordes-Benítez; I Horcajada
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-06       Impact factor: 3.267

Review 4.  The role of water in healthcare-associated infections.

Authors:  Brooke K Decker; Tara N Palmore
Journal:  Curr Opin Infect Dis       Date:  2013-08       Impact factor: 4.915

5.  Gram-negative endocarditis.

Authors:  Milagros P Reyes; Katherine C Reyes
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

6.  Fatal catheter-related bacteremia due to Alcaligenes (Achromobacter) xylosoxidans in a hemodialysis patient.

Authors:  K Turgutalp; A Kiykim; G Ersoz; A Kaya
Journal:  Int Urol Nephrol       Date:  2011-06-03       Impact factor: 2.370

Review 7.  Antimicrobial resistance in hospital-acquired gram-negative bacterial infections.

Authors:  Borna Mehrad; Nina M Clark; George G Zhanel; Joseph P Lynch
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

8.  Achromobacter xylosoxidans Bacteremia and Cellulitis: A Report of a Case.

Authors:  Julia Dai; Auris O Huen; Lori A Kestenbaum; Margaret D Sarezky; Carrie C Coughlin; Albert C Yan
Journal:  Pediatr Dermatol       Date:  2015-05-14       Impact factor: 1.588

9.  Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans.

Authors:  Yongfei Hu; Yuying Zhu; Yanan Ma; Fei Liu; Na Lu; Xi Yang; Chunguang Luan; Yong Yi; Baoli Zhu
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

10.  Pulmonary Infection Caused by Achromobacter xylosoxidans in a Patient with Carcinoma of Epiglottis: A Rare Case.

Authors:  Priyamvada Roy
Journal:  J Clin Diagn Res       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.